22-19766428-G-T

Variant summary

Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM5BP4BS1_SupportingBS2

The NM_001379200.1(TBX1):​c.1076G>T​(p.Gly359Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000201 in 1,344,724 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G359D) has been classified as Pathogenic.

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000022 ( 0 hom. )

Consequence

TBX1
NM_001379200.1 missense

Scores

2
1
13

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 0.907
Variant links:
Genes affected
TBX1 (HGNC:11592): (T-box transcription factor 1) This gene is a member of a phylogenetically conserved family of genes that share a common DNA-binding domain, the T-box. T-box genes encode transcription factors involved in the regulation of developmental processes. This gene product shares 98% amino acid sequence identity with the mouse ortholog. DiGeorge syndrome (DGS)/velocardiofacial syndrome (VCFS), a common congenital disorder characterized by neural-crest-related developmental defects, has been associated with deletions of chromosome 22q11.2, where this gene has been mapped. Studies using mouse models of DiGeorge syndrome suggest a major role for this gene in the molecular etiology of DGS/VCFS. Several alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -4 ACMG points.

PM5
Other missense variant is known to change same aminoacid residue: Variant chr22-19766428-G-A is described in Lovd as [Pathogenic].
BP4
Computational evidence support a benign effect (MetaRNN=0.29645026).
BS1
Variant frequency is greater than expected in population mid. gnomad4_exome allele frequency = 0.0000218 (26/1193356) while in subpopulation MID AF= 0.0006 (2/3334). AF 95% confidence interval is 0.000106. There are 0 homozygotes in gnomad4_exome. There are 16 alleles in male gnomad4_exome subpopulation. Median coverage is 23. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High AC in GnomAdExome4 at 26 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
TBX1NM_001379200.1 linkuse as main transcriptc.1076G>T p.Gly359Val missense_variant 7/7 ENST00000649276.2 NP_001366129.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
TBX1ENST00000649276.2 linkuse as main transcriptc.1076G>T p.Gly359Val missense_variant 7/7 NM_001379200.1 ENSP00000497003 A2
TBX1ENST00000332710.8 linkuse as main transcriptc.1049G>T p.Gly350Val missense_variant 9/91 ENSP00000331791 P2O43435-3
TBX1ENST00000329705.11 linkuse as main transcriptc.1009+426G>T intron_variant 1 ENSP00000331176 A2O43435-1
TBX1ENST00000359500.7 linkuse as main transcriptc.1009+426G>T intron_variant 1 ENSP00000352483 A2O43435-2

Frequencies

GnomAD3 genomes
AF:
0.0000132
AC:
2
AN:
151260
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00321
Gnomad NFE
AF:
0.0000148
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000253
AC:
1
AN:
39464
Hom.:
0
AF XY:
0.0000427
AC XY:
1
AN XY:
23436
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000738
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000218
AC:
26
AN:
1193356
Hom.:
0
Cov.:
23
AF XY:
0.0000274
AC XY:
16
AN XY:
583802
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000205
Gnomad4 OTH exome
AF:
0.0000835
GnomAD4 genome
AF:
0.00000661
AC:
1
AN:
151368
Hom.:
0
Cov.:
33
AF XY:
0.00
AC XY:
0
AN XY:
73986
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000148
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000151

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

DiGeorge syndrome Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpAug 04, 2022This sequence change replaces glycine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 350 of the TBX1 protein (p.Gly350Val). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with TBX1-related conditions. ClinVar contains an entry for this variant (Variation ID: 1508656). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
TBX1-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesDec 16, 2022The TBX1 c.1049G>T variant is predicted to result in the amino acid substitution p.Gly350Val. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0070% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/22-19753951-G-T). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.17
T
BayesDel_noAF
Benign
-0.29
CADD
Benign
20
DANN
Benign
0.91
Eigen
Benign
-0.53
Eigen_PC
Benign
-0.55
FATHMM_MKL
Uncertain
0.88
D
LIST_S2
Benign
0.54
T;T
M_CAP
Pathogenic
0.99
D
MetaRNN
Benign
0.30
T;T
MetaSVM
Benign
-0.51
T
MutationTaster
Benign
1.0
D;D;D
PrimateAI
Pathogenic
0.88
D
PROVEAN
Benign
-0.20
N;.
REVEL
Benign
0.17
Sift
Benign
0.031
D;.
Sift4G
Benign
0.10
T;.
Vest4
0.23
MutPred
0.34
Loss of relative solvent accessibility (P = 0.0676);.;
MVP
0.76
MPC
1.2
ClinPred
0.14
T
GERP RS
2.2
gMVP
0.33

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs781731042; hg19: chr22-19753951; API